Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Superficial sebaceous carcinoma: The correlations between the clinical, dermoscopic and histopathological findings of a rare variant of sebaceous carcinoma.

Mitsui Y, Ogawa K, Fukumoto T, Sasaki C, Sonobe H, Azukizawa H, Koga K, Asada H.

J Dermatol. 2019 Aug;46(8):e280-e281. doi: 10.1111/1346-8138.14843. Epub 2019 Mar 12. No abstract available.

PMID:
30860621
2.

Revival of favus in Japan caused by Trichophyton schoenleinii.

Iwasa K, Ogawa K, Azukizawa H, Tanabe H, Iwanaga T, Anzawa K, Mochizuki T, Asada H.

J Dermatol. 2019 Apr;46(4):347-350. doi: 10.1111/1346-8138.14804. Epub 2019 Feb 15.

PMID:
30768822
3.

Facial pustules due to drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms may histopathologically mimic eosinophilic pustular folliculitis: A case report.

Ogawa K, Mitsui Y, Miyamoto S, Nakamura-Nishimura Y, Nakanishi Y, Azukizawa H, Asada H.

J Cutan Pathol. 2019 May;46(5):363-367. doi: 10.1111/cup.13428. Epub 2019 Feb 18.

PMID:
30666704
4.

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.

Tashiro Y, Azukizawa H, Asada H, Niihara H, Morita E, Yamauchi T, Mizukawa Y, Kusakabe Y, Numazawa S, Izumi M, Sueki H, Watanabe H.

J Dermatol. 2019 Mar;46(3):226-233. doi: 10.1111/1346-8138.14776. Epub 2019 Jan 21.

PMID:
30663091
5.

Anti-PL-12 antibody-positive antisynthetase syndrome with recurrent digital ulcers.

Miyagawa F, Azukizawa H, Mimori T, Asada H.

J Dermatol. 2019 Apr;46(4):e143-e145. doi: 10.1111/1346-8138.14661. Epub 2018 Sep 19. No abstract available.

PMID:
30230582
6.

First Japanese case of atypical Spitz tumor exhibiting ROS1 rearrangement.

Mitsui Y, Ogawa K, Takeda M, Nakanishi T, Azukizawa H, Asada H.

J Dermatol. 2018 Sep;45(9):e248-e249. doi: 10.1111/1346-8138.14293. Epub 2018 Mar 25. No abstract available.

PMID:
29575123
7.

Up-regulation of Human Herpesvirus 6B-derived microRNAs in the Serum of Patients with Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.

Miyashita K, Miyagawa F, Nakamura Y, Ommori R, Azukizawa H, Asada H.

Acta Derm Venereol. 2018 Jun 8;98(6):612-613. doi: 10.2340/00015555-2925. No abstract available.

8.

Preoperative assessment of tumour thickness and vascularity using high-frequency ultrasonography in ten cases of cutaneous melanoma.

Shobatake C, Miyagawa F, Ogawa K, Azukizawa H, Hirai T, Kuwahara M, Asada H.

Eur J Dermatol. 2018 Apr 1;28(2):256-258. doi: 10.1684/ejd.2018.3223. No abstract available.

PMID:
29400300
9.

Serum thymus and activation-regulated chemokine is associated with the severity of drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome.

Nakamura-Nishimura Y, Miyagawa F, Miyashita K, Ommori R, Azukizawa H, Asada H.

Br J Dermatol. 2018 Jun;178(6):1430-1432. doi: 10.1111/bjd.16132. Epub 2018 Mar 25. No abstract available.

PMID:
29150836
10.

Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.

Ono A, Azukizawa H, Ito S, Nakamura Y, Asada H, Quan YS, Kamiyama F, Katayama I, Hirobe S, Okada N.

Int J Pharm. 2017 Oct 30;532(1):374-383. doi: 10.1016/j.ijpharm.2017.08.110. Epub 2017 Aug 30.

PMID:
28855138
11.

Impact of Jumihaidokuto (Shi-Wei-Bai-Du-Tang) on treatment of chronic spontaneous urticaria: A randomized controlled study.

Murota H, Azukizawa H, Katayama I.

Chin J Integr Med. 2017 Aug 17. doi: 10.1007/s11655-017-2950-6. [Epub ahead of print]

PMID:
28819778
12.

First Japanese case report of atypical Spitz tumor with an ALK rearrangement.

Ogawa K, Fukumoto T, Azukizawa H, Takeda M, Asada H.

J Dermatol. 2017 Dec;44(12):e342-e343. doi: 10.1111/1346-8138.14000. Epub 2017 Aug 9. No abstract available.

PMID:
28795421
13.

Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits.

Kato K, Kawase A, Azukizawa H, Hanafusa T, Nakagawa Y, Murota H, Sakaguchi S, Asada H, Katayama I.

J Dermatol Sci. 2017 Jun;86(3):222-229. doi: 10.1016/j.jdermsci.2017.03.007. Epub 2017 Mar 14.

PMID:
28330775
14.

Epidermal growth factor receptor (EGFR) inhibitory monoclonal antibodies and EGFR tyrosine kinase inhibitors have distinct effects on the keratinocyte innate immune response.

Ommori R, Park K, Miyagawa F, Azukizawa H, Kanno M, Asada H.

Br J Dermatol. 2018 Mar;178(3):796-797. doi: 10.1111/bjd.15445. Epub 2018 Jan 25. No abstract available.

PMID:
28294296
15.

Successful treatment with gefitinib after Stevens-Johnson syndrome associated with afatinib therapy in a patient with adenocarcinoma of the lung.

Otsuka T, Tanaka A, Azukizawa H, Sasaki S, Ishijima M, Matsuki T, Osa A, Nakatani T, Kuroyama M, Hirata H, Kijima T.

Int Cancer Conf J. 2016 Nov 5;6(1):38-41. doi: 10.1007/s13691-016-0269-3. eCollection 2017 Jan.

16.

Broad and Largely Concordant Molecular Changes Characterize Tolerogenic and Immunogenic Dendritic Cell Maturation in Thymus and Periphery.

Ardouin L, Luche H, Chelbi R, Carpentier S, Shawket A, Montanana Sanchis F, Santa Maria C, Grenot P, Alexandre Y, Grégoire C, Fries A, Vu Manh TP, Tamoutounour S, Crozat K, Tomasello E, Jorquera A, Fossum E, Bogen B, Azukizawa H, Bajenoff M, Henri S, Dalod M, Malissen B.

Immunity. 2016 Aug 16;45(2):305-18. doi: 10.1016/j.immuni.2016.07.019.

17.

B-1 B cell progenitors transiently and partially express keratin 5 during differentiation in bone marrow.

Hanafusa T, Kato K, Azukizawa H, Miyazaki J, Takeda J, Katayama I.

J Dermatol Sci. 2016 Mar;81(3):173-81. doi: 10.1016/j.jdermsci.2015.11.010. Epub 2015 Nov 30.

PMID:
26655443
18.

Psoriatic Arthritis Complicating Systemic Sclerosis: Possible Involvement of M2 Macrophages.

Yamaoka T, Inoue T, Kitaba S, Yokomi A, Azukizawa H, Terao M, Murota H, Higashiyama M, Katayama I.

Ann Dermatol. 2015 Oct;27(5):631-2. doi: 10.5021/ad.2015.27.5.631. Epub 2015 Oct 2. No abstract available.

19.

Possible association of anti-tumor necrosis factor-α antibody therapy with the development of scleroderma-like changes with lichen planus.

Inoue-Nishimoto T, Hanafusa T, Igawa K, Azukizawa H, Yokomi A, Yokozeki H, Katayama I.

Eur J Dermatol. 2015 Sep-Oct;25(5):513-5. doi: 10.1684/ejd.2015.2631. No abstract available.

PMID:
26242643
20.

Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Aihara M, Kano Y, Fujita H, Kambara T, Matsukura S, Katayama I, Azukizawa H, Miyachi Y, Endo Y, Asada H, Miyagawa F, Morita E, Kaneko S, Abe R, Ochiai T, Sueki H, Watanabe H, Nagao K, Aoyama Y, Sayama K, Hashimoto K, Shiohara T; SJS/TEN Study Group.

J Dermatol. 2015 Aug;42(8):768-77. doi: 10.1111/1346-8138.12925. Epub 2015 May 18.

PMID:
25982480
21.

Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.

Hirobe S, Azukizawa H, Hanafusa T, Matsuo K, Quan YS, Kamiyama F, Katayama I, Okada N, Nakagawa S.

Biomaterials. 2015 Jul;57:50-8. doi: 10.1016/j.biomaterials.2015.04.007. Epub 2015 Apr 24.

PMID:
25913250
22.

Homeostatic NF-κB Signaling in Steady-State Migratory Dendritic Cells Regulates Immune Homeostasis and Tolerance.

Baratin M, Foray C, Demaria O, Habbeddine M, Pollet E, Maurizio J, Verthuy C, Davanture S, Azukizawa H, Flores-Langarica A, Dalod M, Lawrence T.

Immunity. 2015 Apr 21;42(4):627-39. doi: 10.1016/j.immuni.2015.03.003. Epub 2015 Apr 7.

23.

Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).

Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, Iijima M, Morita E, Niihara H, Asada H, Kabashima K, Azukizawa H, Hashizume H, Nagao K, Takahashi H, Abe R, Sotozono C, Kurosawa M, Aoyama Y, Chu CY, Chung WH, Shiohara T.

J Dermatol. 2015 Mar;42(3):276-82. doi: 10.1111/1346-8138.12770. Epub 2015 Jan 27.

PMID:
25623158
24.

Development of necrotising fasciitis in a patient treated for rheumatoid arthritis with tocilizumab.

Hashimoto N, Yamaoka T, Koguchi-Yoshioka H, Tanaka A, Tanemura A, Azukizawa H, Murota H, Kang J, Nakagawa Y, Shimazu T, Katayama I.

Acta Derm Venereol. 2015 Mar;95(3):370-1. doi: 10.2340/00015555-1952. No abstract available.

25.

Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.

Chung WH, Chang WC, Lee YS, Wu YY, Yang CH, Ho HC, Chen MJ, Lin JY, Hui RC, Ho JC, Wu WM, Chen TJ, Wu T, Wu YR, Hsih MS, Tu PH, Chang CN, Hsu CN, Wu TL, Choon SE, Hsu CK, Chen DY, Liu CS, Lin CY, Kaniwa N, Saito Y, Takahashi Y, Nakamura R, Azukizawa H, Shi Y, Wang TH, Chuang SS, Tsai SF, Chang CJ, Chang YS, Hung SI; Taiwan Severe Cutaneous Adverse Reaction Consortium; Japan Pharmacogenomics Data Science Consortium.

JAMA. 2014 Aug 6;312(5):525-34. doi: 10.1001/jama.2014.7859.

PMID:
25096692
26.

Immune reconstitution inflammatory syndrome in a patient with adult-onset Still's disease: graft-versus-host-like skin reaction with possible asymptomatic human herpes virus reactivation during steroid tapering.

Yamaga K, Hanafusa T, Azukizawa H, Tanemura A, Nii T, Nishide M, Narazaki M, Katayama I.

Eur J Dermatol. 2014 Jan-Feb;24(1):101-3. doi: 10.1684/ejd.2013.2218. No abstract available.

PMID:
24334185
27.

Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device.

Hirobe S, Azukizawa H, Matsuo K, Zhai Y, Quan YS, Kamiyama F, Suzuki H, Katayama I, Okada N, Nakagawa S.

Pharm Res. 2013 Oct;30(10):2664-74. doi: 10.1007/s11095-013-1092-6. Epub 2013 Jun 18.

PMID:
23775442
28.

Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model.

Nakajima K, Terao M, Takaishi M, Kataoka S, Goto-Inoue N, Setou M, Horie K, Sakamoto F, Ito M, Azukizawa H, Kitaba S, Murota H, Itami S, Katayama I, Takeda J, Sano S.

J Invest Dermatol. 2013 Nov;133(11):2555-2565. doi: 10.1038/jid.2013.199. Epub 2013 Apr 30.

29.

Toxic epidermal necrolysis complicated by sepsis, haemophagocytic syndrome, and severe liver dysfunction associated with elevated interleukin-10 production.

Yamaoka T, Azukizawa H, Tanemura A, Murota H, Hirose T, Hayakawa K, Shimazu T, Wada N, Morii E, Katayama I.

Eur J Dermatol. 2012 Nov-Dec;22(6):815-7. doi: 10.1684/ejd.2012.1870. No abstract available.

PMID:
23178237
30.

Non-pigmenting fixed drug eruption caused by an over-the-counter non-steroidal anti-inflammatory drug: drug-specific CD8+ T lymphocytes identified in peripheral blood.

Hanafusa T, Azukizawa H, Matsumura S, Murakami Y, Tanaka A, Kurachi K, Katayama I.

Eur J Dermatol. 2012 Sep-Oct;22(5):680-2. doi: 10.1684/ejd.2012.1793. No abstract available.

PMID:
22854000
31.

Systemic allergic contact dermatitis to palladium inlay manifesting as annular erythema.

Hanafusa T, Yoshioka E, Azukizawa H, Itoi S, Tani M, Kira M, Katayama I.

Eur J Dermatol. 2012 Sep-Oct;22(5):697-8. doi: 10.1684/ejd.2012.1794. No abstract available.

PMID:
22759481
32.

The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity.

Hanafusa T, Azukizawa H, Matsumura S, Katayama I.

J Dermatol Sci. 2012 Mar;65(3):213-9. doi: 10.1016/j.jdermsci.2011.12.002. Epub 2011 Dec 17.

PMID:
22226608
33.

Lichen planus-type chronic graft-versus-host disease complicated by mucous membrane pemphigoid with positive anti-BP180/230 and scleroderma-related autoantibodies followed by reduced regulatory T cell frequency.

Hanafusa T, Azukizawa H, Nishioka M, Tanemura A, Murota H, Yoshida H, Sato E, Hashii Y, Ozono K, Koga H, Hashimoto T, Katayama I.

Eur J Dermatol. 2012 Jan-Feb;22(1):140-2. doi: 10.1684/ejd.2011.1587. No abstract available.

PMID:
22217601
34.

Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma.

Kitaba S, Murota H, Terao M, Azukizawa H, Terabe F, Shima Y, Fujimoto M, Tanaka T, Naka T, Kishimoto T, Katayama I.

Am J Pathol. 2012 Jan;180(1):165-76. doi: 10.1016/j.ajpath.2011.09.013. Epub 2011 Nov 7.

PMID:
22062222
35.

Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course.

Hanafusa T, Azukizawa H, Kitaba S, Murota H, Umegaki N, Terao M, Sano S, Nakagiri T, Okumura M, Katayama I.

Clin Exp Immunol. 2011 Nov;166(2):164-70. doi: 10.1111/j.1365-2249.2011.04472.x.

36.

Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8α+ type.

Crozat K, Tamoutounour S, Vu Manh TP, Fossum E, Luche H, Ardouin L, Guilliams M, Azukizawa H, Bogen B, Malissen B, Henri S, Dalod M.

J Immunol. 2011 Nov 1;187(9):4411-5. doi: 10.4049/jimmunol.1101717. Epub 2011 Sep 23.

37.

Acute generalized exanthematous pustulosis induced by topical diphenhydramine.

Hanafusa T, Igawa K, Azukizawa H, Katayama I.

Eur J Dermatol. 2011 Nov-Dec;21(6):994-5. doi: 10.1684/ejd.2011.1500. No abstract available.

PMID:
21856562
38.

Peculiar distribution of tumorous xanthomas in an adult case of erdheim-chester disease complicated by atopic dermatitis.

Murakami Y, Wataya-Kaneda M, Terao M, Azukizawa H, Murota H, Nakata Y, Katayama I.

Case Rep Dermatol. 2011 May;3(2):107-12. doi: 10.1159/000328797. Epub 2011 May 17.

39.

Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells.

Azukizawa H, Döhler A, Kanazawa N, Nayak A, Lipp M, Malissen B, Autenrieth I, Katayama I, Riemann M, Weih F, Berberich-Siebelt F, Lutz MB.

Eur J Immunol. 2011 May;41(5):1420-34. doi: 10.1002/eji.201040930. Epub 2011 Apr 14.

40.

Clinical implications of leukocytapheresis using a centrifugal cell separator for steroid-resistant pyoderma gangrenosum associated with inflammatory bowel disease.

Hanafusa T, Azukizawa H, Umegaki N, Tani M, Yamaguchi Y, Katayama I.

J Dermatol. 2011 May;38(5):507-10. doi: 10.1111/j.1346-8138.2010.01009.x. Epub 2010 Sep 20. No abstract available.

PMID:
21352279
41.

Animal models of toxic epidermal necrolysis.

Azukizawa H.

J Dermatol. 2011 Mar;38(3):255-60. doi: 10.1111/j.1346-8138.2010.01173.x. Review.

PMID:
21342227
42.

Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases.

Murota H, Kitaba S, Tani M, Wataya-Kaneda M, Azukizawa H, Tanemura A, Umegaki N, Terao M, Kotobuki Y, Katayama I.

Allergol Int. 2010 Dec;59(4):345-54. doi: 10.2332/allergolint.10-OA-0182. Epub 2010 Aug 25.

43.

Antigen-specific CD8 T cells can eliminate antigen-bearing keratinocytes with clonogenic potential via an IFN-gamma-dependent mechanism.

De Kluyver RL, Moritz L, Harris CA, Azukizawa H, Frazer IH.

J Invest Dermatol. 2010 Jul;130(7):1841-8. doi: 10.1038/jid.2010.49. Epub 2010 Mar 18.

44.

Revisiting the tolerogenicity of epidermal Langerhans cells.

Lutz MB, Döhler A, Azukizawa H.

Immunol Cell Biol. 2010 May-Jun;88(4):381-6. doi: 10.1038/icb.2010.17. Epub 2010 Mar 9. Review.

PMID:
20212507
45.

Antigen-specific CD4 cells assist CD8 T-effector cells in eliminating keratinocytes.

Broom JK, Lew AM, Azukizawa H, Kenna TJ, Leggatt GR, Frazer IH.

J Invest Dermatol. 2010 Jun;130(6):1581-9. doi: 10.1038/jid.2010.17. Epub 2010 Feb 11.

46.

CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells.

Henri S, Poulin LF, Tamoutounour S, Ardouin L, Guilliams M, de Bovis B, Devilard E, Viret C, Azukizawa H, Kissenpfennig A, Malissen B.

J Exp Med. 2010 Jan 18;207(1):189-206. doi: 10.1084/jem.20091964. Epub 2009 Dec 28. Erratum in: J Exp Med. 2010 Feb 15;207(2):447.

47.

Recurrent contact cheilitis because of glyceryl isostearate, diisostearyl maleate, oleyl alcohol, and Lithol Rubine BCA in lipsticks.

Inui S, Azukizawa H, Katayama I.

Contact Dermatitis. 2009 Apr;60(4):231-2. doi: 10.1111/j.1600-0536.2009.01513.x. No abstract available.

PMID:
19338598
48.

Novel functional aspect of antihistamines: the impact of bepotastine besilate on substance p-induced events.

Kitaba S, Murota H, Yahata Y, Azukizawa H, Katayama I.

J Allergy (Cairo). 2009;2009:853687. doi: 10.1155/2009/853687. Epub 2009 Jun 21.

49.

[Case of urticaria due to cochineal dye in red-colored diet].

Kotobuki Y, Azukizawa H, Nishida Y, Murota H, Katayama I, Yoshikawa K.

Arerugi. 2007 Dec;56(12):1510-4. Japanese.

PMID:
18195555
50.

Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells.

Waithman J, Allan RS, Kosaka H, Azukizawa H, Shortman K, Lutz MB, Heath WR, Carbone FR, Belz GT.

J Immunol. 2007 Oct 1;179(7):4535-41.

Supplemental Content

Loading ...
Support Center